SI3968956T1 - Topični farmacevtski mupirocinski sestavek za bakterijske infekcije in celjenje ran - Google Patents
Topični farmacevtski mupirocinski sestavek za bakterijske infekcije in celjenje ranInfo
- Publication number
- SI3968956T1 SI3968956T1 SI202030448T SI202030448T SI3968956T1 SI 3968956 T1 SI3968956 T1 SI 3968956T1 SI 202030448 T SI202030448 T SI 202030448T SI 202030448 T SI202030448 T SI 202030448T SI 3968956 T1 SI3968956 T1 SI 3968956T1
- Authority
- SI
- Slovenia
- Prior art keywords
- wound healing
- bacterial infections
- topical pharmaceutical
- mupirocin
- composition
- Prior art date
Links
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 229960003128 mupirocin Drugs 0.000 title 1
- 229930187697 mupirocin Natural products 0.000 title 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 230000029663 wound healing Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941043186 | 2019-10-24 | ||
| PCT/IB2020/059815 WO2021079254A1 (en) | 2019-10-24 | 2020-10-19 | A topical antibiotic containing pharmaceutical composition for bacterial infections and wound healing |
| EP20803921.4A EP3968956B1 (en) | 2019-10-24 | 2020-10-19 | A topical pharmaceutical mupirocin composition for bacterial infections and wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3968956T1 true SI3968956T1 (sl) | 2024-08-30 |
Family
ID=73198358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI202030448T SI3968956T1 (sl) | 2019-10-24 | 2020-10-19 | Topični farmacevtski mupirocinski sestavek za bakterijske infekcije in celjenje ran |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20230190647A1 (sl) |
| EP (1) | EP3968956B1 (sl) |
| JP (1) | JP7441943B2 (sl) |
| KR (1) | KR20220087501A (sl) |
| CN (1) | CN114364370B (sl) |
| AR (1) | AR120293A1 (sl) |
| AU (1) | AU2020369219A1 (sl) |
| BR (1) | BR112022004949A2 (sl) |
| CA (1) | CA3144877A1 (sl) |
| DK (1) | DK3968956T3 (sl) |
| FI (1) | FI3968956T3 (sl) |
| HR (1) | HRP20240841T1 (sl) |
| LT (1) | LT3968956T (sl) |
| MX (1) | MX2022001532A (sl) |
| PL (1) | PL3968956T3 (sl) |
| PT (1) | PT3968956T (sl) |
| RS (1) | RS65709B1 (sl) |
| SI (1) | SI3968956T1 (sl) |
| WO (1) | WO2021079254A1 (sl) |
| ZA (1) | ZA202201884B (sl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137363A (en) | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| EP2410975A1 (en) * | 2009-03-25 | 2012-02-01 | Sulur Subramaniam Vanangamudi | A medicinal antibacterial cream and a process to make it |
| WO2010109434A2 (en) * | 2009-03-25 | 2010-09-30 | Sulur Subramaniam Vanangamudi | A medicinal antibacterial, antifungal and steroids cream and a process to make it |
| WO2010122478A1 (en) * | 2009-04-20 | 2010-10-28 | Sulur Subramaniam Vanangamudi | A medicinal antibacterial and steroids cream incorporating a biopolymer and a process to make it |
| TWI445557B (zh) * | 2011-05-24 | 2014-07-21 | To induce new bone formation around the implant compositions | |
| CN202505827U (zh) * | 2012-03-30 | 2012-10-31 | 深圳市源兴纳米医药科技有限公司 | 一种含纳米银的止血消炎抗菌敷贴 |
| JP6495183B2 (ja) * | 2013-01-30 | 2019-04-03 | ボリス ゴリンステイン | 表面の創傷を処置するための組成物および方法 |
| KR101457789B1 (ko) * | 2013-02-13 | 2014-11-03 | 동아제약 주식회사 | 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법 |
| CN106039394A (zh) * | 2016-06-02 | 2016-10-26 | 四川奎星医用高分子制品有限责任公司 | 含有抗菌药物的医用复合壳聚糖凝胶 |
-
2020
- 2020-10-19 DK DK20803921.4T patent/DK3968956T3/da active
- 2020-10-19 AU AU2020369219A patent/AU2020369219A1/en active Pending
- 2020-10-19 JP JP2022523839A patent/JP7441943B2/ja active Active
- 2020-10-19 RS RS20240715A patent/RS65709B1/sr unknown
- 2020-10-19 SI SI202030448T patent/SI3968956T1/sl unknown
- 2020-10-19 US US17/635,644 patent/US20230190647A1/en active Pending
- 2020-10-19 EP EP20803921.4A patent/EP3968956B1/en active Active
- 2020-10-19 FI FIEP20803921.4T patent/FI3968956T3/fi active
- 2020-10-19 WO PCT/IB2020/059815 patent/WO2021079254A1/en active Application Filing
- 2020-10-19 PL PL20803921.4T patent/PL3968956T3/pl unknown
- 2020-10-19 PT PT208039214T patent/PT3968956T/pt unknown
- 2020-10-19 LT LTEPPCT/IB2020/059815T patent/LT3968956T/lt unknown
- 2020-10-19 BR BR112022004949A patent/BR112022004949A2/pt unknown
- 2020-10-19 HR HRP20240841TT patent/HRP20240841T1/hr unknown
- 2020-10-19 CA CA3144877A patent/CA3144877A1/en active Pending
- 2020-10-19 CN CN202080062383.9A patent/CN114364370B/zh active Active
- 2020-10-19 MX MX2022001532A patent/MX2022001532A/es unknown
- 2020-10-19 KR KR1020227016947A patent/KR20220087501A/ko active Search and Examination
- 2020-10-23 AR ARP200102941A patent/AR120293A1/es unknown
-
2022
- 2022-02-14 ZA ZA2022/01884A patent/ZA202201884B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022001532A (es) | 2022-03-11 |
| HRP20240841T1 (hr) | 2024-10-11 |
| DK3968956T3 (da) | 2024-06-24 |
| WO2021079254A1 (en) | 2021-04-29 |
| KR20220087501A (ko) | 2022-06-24 |
| RS65709B1 (sr) | 2024-08-30 |
| CN114364370B (zh) | 2024-09-06 |
| JP2023501910A (ja) | 2023-01-20 |
| BR112022004949A2 (pt) | 2022-08-23 |
| AR120293A1 (es) | 2022-02-09 |
| CA3144877A1 (en) | 2021-04-29 |
| PL3968956T3 (pl) | 2024-08-19 |
| FI3968956T3 (fi) | 2024-07-03 |
| EP3968956B1 (en) | 2024-04-10 |
| JP7441943B2 (ja) | 2024-03-01 |
| CN114364370A (zh) | 2022-04-15 |
| EP3968956A1 (en) | 2022-03-23 |
| PT3968956T (pt) | 2024-07-15 |
| US20230190647A1 (en) | 2023-06-22 |
| AU2020369219A1 (en) | 2022-01-20 |
| LT3968956T (lt) | 2024-07-10 |
| ZA202201884B (en) | 2022-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4144358A4 (en) | ANTIBACTERIAL ANTIVIRAL PHARMACEUTICAL COMPOSITION AND ITS USE | |
| EP3700504A4 (en) | TOPICAL PHARMACEUTICAL COMPOSITION OF ADAPALENE AND MINOCYCLINE | |
| EP3584245A4 (en) | TRIAZOLE ANTIBACTERIAL DERIVATIVE, ASSOCIATED PHARMACEUTICAL COMPOSITION AND USE | |
| EP3714887A4 (en) | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION AND RELATED PREPARATION PROCESS | |
| EP3858353A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NITM AND ASSOCIATED PHARMACEUTICAL USE | |
| EP4023227A4 (en) | PHARMACEUTICAL COMPOSITION AND ITS APPLICATION | |
| EP4223759A4 (en) | PYRAZOLOPYRIDAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE | |
| EP4103539A4 (en) | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | |
| IL288861A (en) | A drug and its use for the treatment of bacterial infections associated with biofilm | |
| EP4114355C0 (en) | TOPICAL COMPOSITION WITH CANNABIDIOL | |
| EP4076420A4 (en) | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS AND POTENTIFYING ANTIBIOTICS | |
| LT3968956T (lt) | Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui | |
| EP3805210A4 (en) | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THEM | |
| EP3697433A4 (en) | TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS | |
| EP4095141A4 (en) | Cephalosporin antibacterial compound and pharmaceutical application thereof | |
| EP4070791A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING STEROID COMPOUND AND OLOPATADINE | |
| EP4015516A4 (en) | N-ACYLHYDRAZONE DERIVATIVE BASED ON BENZOFURAN AND PHARMACEUTICAL COMPOSITION CONTAINING THESE | |
| EP4025562A4 (en) | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | |
| EP3773641A4 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS | |
| AU2019903188A0 (en) | Topical Pharmaceutical Formulation for Wound Treatment | |
| AU2020903123A0 (en) | Topical Pharmaceutical Formulation for Wound Treatment | |
| EP3845218A4 (en) | PHARMACEUTICAL COMPOSITION FOR WOUND HEALING | |
| AU2018903193A0 (en) | Topical Pharmaceutical Formulation for Wound Treatment | |
| EP4108235C0 (en) | TOPICAL PHARMACEUTICAL FORMULATION | |
| KR102109168B9 (ko) | 신규 화합물 및 이를 포함하는 진균감염 치료용 약학적 조성물 |